tomeko

Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency

Just diagnosed with Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency, look for clinical trials, and connect with others living with it — all in one place.

Open the full Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency hub →

Overview

Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency is a rare condition. Also known as Hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form. Tomeko brings together the specialists, research, clinical trials, treatments and community for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:276598 · OMIM 256450 · ICD-10 E16.1 · GARD 0017285

Find care for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency

Authoritative references for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency

Common questions

I was just diagnosed with Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency, filtered to your area.

Are there clinical trials for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency?

Tomeko shows live, recruiting studies for Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com